MCRB icon

Seres Therapeutics
MCRB

Overview Fund Activity

76 hedge funds and large institutions have $820M invested in Seres Therapeutics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 4 closing their positions.

Holders
76
Holders Change
+7
Holders Change %
+10.14%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
36
Reduced
13
Closed
4
Calls
$931K
Puts
$1.52M
Net Calls
-$592K
Net Calls Change
-$2.44M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$25.2M
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$27.6M
3
BM
3
Bridger Management
New York
$18.9M
4
BA
4
BlackRock Advisors
Delaware
$17.3M
5
PCM
5
Portolan Capital Management
Massachusetts
$3.17M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$253K
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$0
3
KCM
3
Kennedy Capital Management
Missouri
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$25.3M
5
OPPM
5
Opus Point Partners Management
New York
$645K
Name Market Value Shares Shares
Change 		Shares
Change %
Geode Capital Management
76
Geode Capital Management
Massachusetts
$2.04K 3,849 +94 +3%
Lord, Abbett & Co
77
Lord, Abbett & Co
New Jersey
– – -4,144 Closed
KCM
78
Kennedy Capital Management
Missouri
– – -722 Closed
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
– – -1 Closed
Simplex Trading
80
Simplex Trading
Illinois
– – -1 Closed
1 2 3
4